Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.028
Neutral
RSI(14)
52.176
Neutral
STOCH(KDJ)(9,3,3)
36.839
Buy
ATR(14)
0.073
High Vlolatility
CCI(14)
-41.894
Neutral
Williams %R
48.991
Neutral
TRIX(12,20)
0.039
Sell
StochRSI(14)
98.036
Buy
Femasys Inc
FEMY0.861USD
+0.064+7.97%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
40.73MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Femasys Inc
Currency: USD Updated: 2025-12-19Key Insights
Femasys Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 132/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.17.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Femasys Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
5.167
Target Price
+532.01%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Femasys Inc Highlights
StrengthsRisks
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.06% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.63M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.63M.
Fairly Valued
The company’s latest PE is -1.25, at a medium 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 951.87K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.15.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Femasys Inc is 5.96, ranking 182/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 729.39K, representing a year-over-year increase of 31.44%, while its net profit experienced a year-over-year increase of 22.45%.
Score
Financials
6.22
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.89
Operational Efficiency
2.83
Growth Potential
5.79
Shareholder Returns
7.07
Femasys Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Femasys Inc is 6.05, ranking 178/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.25, which is -74.65% below the recent high of -0.32 and -216.62% above the recent low of -3.97.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 132/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Femasys Inc is 8.00, ranking 59/208 in the Healthcare Equipment & Supplies industry. The average price target for Femasys Inc is 6.00, with a high of 6.50 and a low of 3.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
5.167
Target Price
+532.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
112
Total
6
Median
9
Average
Company name
Ratings
Analysts
Femasys Inc
FEMY
3
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Femasys Inc is 6.73, ranking 120/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.01 and the support level at 0.73, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.829
Buy
MA10
0.836
Buy
MA20
0.882
Sell
MA50
0.789
Buy
MA100
0.663
Buy
MA200
0.878
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Femasys Inc is 3.00, ranking 135/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 9.41%, representing a quarter-over-quarter decrease of 13.87%. The largest institutional shareholder is The Vanguard, holding a total of 951.87K shares, representing 1.63% of shares outstanding, with 46.60% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Chernett (Jorey)
Dauntless Investment Group, LLC
Uzialko (Edward R Jr.)
Alumni Capital Management LLC
Lee-Sepsick (Kathy)
Geode Capital Management, L.L.C.
Clear Creek Financial Management, LLC
Currie (Daniel Scott)
BlackRock Institutional Trust Company, N.A.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Femasys Inc is 1.23, ranking 196/208 in the Healthcare Equipment & Supplies industry. The company's beta value is -2.49. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
-2.49
VaR
--
240-Day Maximum Drawdown
+80.54%
240-Day Volatility
+141.45%
Return
Best Daily Return
60 days
+51.87%
120 days
+51.87%
5 years
--
Worst Daily Return
60 days
-20.09%
120 days
-27.00%
5 years
--
Sharpe Ratio
60 days
+2.73
120 days
+0.57
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+80.54%
3 years
+91.15%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.29
3 years
-0.10
5 years
--
Skewness
240 days
+2.08
3 years
+15.33
5 years
--
Volatility
Realised Volatility
240 days
+141.45%
5 years
--
Standardised True Range
240 days
+10.65%
5 years
--
Downside Risk-Adjusted Return
120 days
+111.97%
240 days
+111.97%
Maximum Daily Upside Volatility
60 days
+206.49%
Maximum Daily Downside Volatility
60 days
+108.65%
Liquidity
Average Turnover Rate
60 days
+2.49%
120 days
+2.06%
5 years
--
Turnover Deviation
20 days
+15.29%
60 days
-45.64%
120 days
-54.93%
Peer Comparison
Healthcare Equipment & Supplies
Femasys Inc
FEMY
5.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Femasys Inc?
The TradingKey Stock Score provides a comprehensive assessment of Femasys Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Femasys Inc’s performance and outlook.
How do we generate the financial health score of Femasys Inc?
To generate the financial health score of Femasys Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Femasys Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Femasys Inc.
How do we generate the company valuation score of Femasys Inc?
To generate the company valuation score of Femasys Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Femasys Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Femasys Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Femasys Inc.
How do we generate the earnings forecast score of Femasys Inc?
To calculate the earnings forecast score of Femasys Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Femasys Inc’s future.
How do we generate the price momentum score of Femasys Inc?
When generating the price momentum score for Femasys Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Femasys Inc’s prices. A higher score indicates a more stable short-term price trend for Femasys Inc.
How do we generate the institutional confidence score of Femasys Inc?
To generate the institutional confidence score of Femasys Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Femasys Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Femasys Inc.
How do we generate the risk management score of Femasys Inc?
To assess the risk management score of Femasys Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Femasys Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Femasys Inc.
